<p>Polycystic kidney disease is a cystic genetic disorder of the kidneys. Recent identification of signaling cascades de-regulated in PKD has led to the initiation of several clinical trials, but an effective therapy is still lacking. Here is claimed a new therapeutic paradigm capable to improve the proliferation rate and cystic kidney volume in PKD.</p>
